ARCHIVES

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002

Community Clinical Oncology Program Renewed, NCI Hopes To Restore Cuts In ’08.

March 30, 2007

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004